ChatGPT-Supported Text Messaging Program for Smoking Cessation
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: BeFree+Bot, BeFree.
- Who it may be relevant to
- Registry conditions: Smoking Cessation. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Engagement and Satisfaction With a ChatGPT-Supported Text Messaging Program for Smoking Cessation
Overview
The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and BeFree.
Interventions
- Behavioral BeFree+Bot
Text messaging program called BeFree and access to BBot, ChatGPT chatbot - Behavioral BeFree
Text messaging program called BeFree
Primary outcome measures
- Continuous abstinence [Time frame: at 1 month follow-up]
Eligibility criteria
Inclusion criteria
- lives in the US
- smoked a cigarette within the last 7 days
- has a mobile phone
- willing to receive text messages about the health effects of smoking on their mobile phone for 30 days
Exclusion criteria
- none
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
United States · 1 center
- Prolific — Washington D.C.
Identifiers
NCT: NCT07079306 · GWUniversity